| Matt Zarinnia, | |
|
16133 Ventura Blvd Ste 1100, Encino, CA 91436-2415 | |
| (310) 867-0636 | |
| Not Available |
| Full Name | Matt Zarinnia |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 16133 Ventura Blvd Ste 1100, Encino, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699837823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 55400 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matt Zarinnia, 16133 Ventura Blvd Ste 1100, Encino, CA 91436-2415 Ph: (310) 867-0636 | Matt Zarinnia, 16133 Ventura Blvd Ste 1100, Encino, CA 91436-2415 Ph: (310) 867-0636 |
News Archive
GTx, Inc. today presented additional results from the Ostarine™ Phase IIb study demonstrating an improvement in quality of life (fatigue and anorexia) in cancer patients with muscle wasting (cancer cachexia) who demonstrated improvement in functional performance as measured by stair climb. Ostarine (GTx-024) is GTx's lead selective androgen receptor modulator (SARM) which the company is developing for the treatment of cancer cachexia.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.
Mitochondria are the body's energy producers, the power stations inside our cells. Researchers at the University of Gothenburg, Sweden, have now identified a group of mitochondrial proteins, the absence of which allows other protein groups to stabilise the genome. This could delay the onset of age-related diseases and increase lifespan.
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
› Verified 2 days ago
Dr. Lecia Erin Harmer, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 6345 Balboa Blvd Ste 314, Encino, CA 91316 Phone: 818-943-8228 Fax: 509-271-7372 | |
Jeremiah Beisel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 15720 Ventura Blvd Ste 301, Encino, CA 91436 Phone: 818-788-7181 Fax: 818-907-1891 | |
Mr. Steven Yoshiharu Shiba, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 16311 Ventura Blvd, #1075, Encino, CA 91436 Phone: 818-783-2770 Fax: 818-788-0494 | |
Roya Delafraz, Dentist Medicare: Not Enrolled in Medicare Practice Location: 15760 Ventura Blvd Ste 606, Encino, CA 91436 Phone: 818-981-9143 | |
Dr. Jeffrey B Ballen, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 5363 Balboa Blvd, Suite 534, Encino, CA 91316 Phone: 818-986-6777 | |
Dr. Richard Lee Kahn, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 16406 Moorpark St, Encino, CA 91436 Phone: 213-740-8084 | |
Dr. Kory Michael Zussman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 16311 Ventura Blvd Ste 625, Encino, CA 91436 Phone: 818-907-1318 |